HR 9616 · 118th Congress · Health
Prompt Approval of Safe Generic Drugs Act
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the House Committee on Energy and Commerce.(2024-09-17)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 9616 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 9616 To amend the Federal Food, Drug, and Cosmetic Act to provide for the prompt approval of drugs when safety information is added to labeling, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 17, 2024 Ms. Barragan introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to provide for the prompt approval of drugs when safety information is added to labeling, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Prompt Approval of Safe Generic Drugs Act''. SEC. 2. PROMPT APPROVAL OF DRUGS WHEN SAFETY INFORMATION IS ADDED TO LABELING. Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended by adding at the end the …
Summarized by Claude AI · Non-partisan · For informational purposes only